Indaptus Therapeutics Files 8-K
Ticker: INDP · Form: 8-K · Filed: May 22, 2024 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, disclosure
TL;DR
Indaptus Therapeutics filed an 8-K, but the details are scarce.
AI Summary
Indaptus Therapeutics, Inc. filed an 8-K on May 22, 2024, reporting an event under 'Other Events'. The company, formerly known as Intec Parent Inc. until April 14, 2021, is incorporated in Delaware and headquartered in New York. This filing does not contain specific financial figures or details about the 'Other Events'.
Why It Matters
This filing indicates a corporate event has occurred for Indaptus Therapeutics, Inc., requiring disclosure to the SEC, though the specific nature of the event is not detailed in the provided text.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk for investors.
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Registrant
- Intec Parent Inc. (company) — Former company name
- May 22, 2024 (date) — Date of report
- April 14, 2021 (date) — Date of former name change
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal executive offices city
FAQ
What specific event is being reported under 'Other Events' in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events'.
When did Indaptus Therapeutics, Inc. change its name from Intec Parent Inc.?
Indaptus Therapeutics, Inc. changed its name from Intec Parent Inc. on April 14, 2021.
What is the principal executive office address for Indaptus Therapeutics, Inc.?
The principal executive offices are located at 3 Columbus Circle, 15th Floor, New York, NY 10019.
What is the IRS Employer Identification Number for Indaptus Therapeutics, Inc.?
The IRS Employer Identification Number for Indaptus Therapeutics, Inc. is 86-3158720.
What is the SIC code for Indaptus Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Indaptus Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,047 words · 4 min read · ~3 pages · Grade level 18.7 · Accepted 2024-05-22 08:00:18
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INDP Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-020966.txt ( ) — 208KB
- indp-20240522.xsd (EX-101.SCH) — 3KB
- indp-20240522_lab.xml (EX-101.LAB) — 33KB
- indp-20240522_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 22, 2024 INDAPTUS THERAPEUTICS, INC. By: /s/ Nir Sassi Name: Nir Sassi Title: Chief Financial Officer